Molnupiravir 2349386-89-4

99% up by HPLC

Produktkategorien

Neue Produkte

Produktdetails

Product Information

Product name	Molnupiravir / EIDD-2801 / MK448
CAS No.	2349386-89-4
Molecular Formula	C13H19N3O7
Molecular Weight	329.31
Quality Standard	98% up by HPLC
Appearance	White powder

COA of Molnupiravir

ITEMS	SPECIFICATION	RESULT
Appearance	White to off-white powder	White powder
Solubility	Sparingly soluble in methanol ,practically insoluble in water	Complies
Identity	IR Spectrum of the test is concordant with the IR spectrum of the standard, obtained in the samemanner.	Complies
Related Substance	Any single impurity not more than 0.1%	0.04%
Related Substance	Total impurities are not more than1.0%	0.1%
Limit of residual solvents	2-propanol ≤ 5000ppm	75 ppm
	Ethanol ≤ 5000ppm	162 ppm
	Ethyl acetate ≤ 5000ppm	Not detected
	Cyclohexane ≤ 3880ppm	1 ppm
Loss on drying	≤ 0.5%	0.12%
Residue on ignition	≤ 0.1%	0.03%
Heavy metals	≤ 0.02%	Complies
Assay	98.0～102.0%	99.5%
Conclusion	Complies with the specification

Usage

Function of Molnupiravir

Molnupiravir / EIDD-2801 is an orally bioavailable prodrug of the ribonucleoside analog EIDD-1931. EIDD-2801 has broad-spectrum antiviral activity against influenza virus and multiple coronaviruses (e.g., SARS-ChemicalbookCoV-2, MERS-CoV, SARS-CoV). EIDD-2801 has the potential to treat the novel coronavirus COVID-19 as well as seasonal and pandemic influenza.